https://www.mdsabstracts.org/abstract/preclinical-pharmacology-and-early-clinical-development-of-dopamine-d1-positive-allosteric-modulators-d1pams-with-therapeutic-potential-for-neuropsychiatric-disorders/
Preclinical pharmacology and early clinical development of dopamine D1 positive allosteric...
Objective: The objective was to characterize novel dopamine D1PAMs pre-clinically in behavioral and neurochemical models and in phase 1 human studies in...
early clinical developmentpreclinical pharmacology
https://lumanity.com/perspectives/indication-prioritization-and-early-clinical-development-roadmap-for-a-broadly-applicable-t-cell-modulatory-therapy/
Indication Prioritization and Early Clinical Development Roadmap
Jun 18, 2024 - An emerging biotech company with a novel platform to modulate T-cells, potentially enabling a reset of the immune system and restoration of immune homeostasis.
early clinical developmentindicationprioritizationroadmap